NCT00712595View on ClinicalTrials.gov

Mifepristone for Treatment of Uterine Fibroids

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2007

Study Completion Date

March 31, 2009

Conditions
Uterine Fibroids
Interventions
DRUG

Mifepristone

Oral administration of Mifepristone 10 mg daily for three months

DRUG

Mifepristone

Oral administration of Mifepristone 5 mg, daily for three months

Trial Locations (1)

11400

Hospital Eusebio Hernández, Havana

All Listed Sponsors
lead

Mediterranea Medica S. L.

OTHER

NCT00712595 - Mifepristone for Treatment of Uterine Fibroids | Biotech Hunter | Biotech Hunter